You just read:

Eisai is Appalled by Arbitrary Decision to Remove Life-Extending Breast Cancer Therapy Halaven® (Eribulin) From Cancer Drugs Fund

News provided by

Eisai Europe Limited

08 Jan, 2015, 00:01 GMT